AccelLAB Is Now Part of Charles River

As the most recent addition to the Charles River team, we’re thrilled to be able to offer you even more of the science and service you know and trust, along with the added capacity and insight made possible through Charles River’s global network of leading laboratory facilities.

Connect with your AccelLab expert today

AccelLAB logo over image of cells.

Support for Your Medical Device Safety Assessment Program

From stents to regenerative medicines, the highly diverse medical device manufacturing sector is known for producing cutting-edge products using advanced technology. Subject to stringent regulations, medical devices require expert assessment of safety and efficacy before they can be manufactured and brought to market. With a commitment to scientific excellence, a deep understanding of regulatory requirements, and programs built to suit our clients’ needs, Charles River partners with you to create integrated solutions for your medical device studies.


Meet the Team

The scientists joining from AccelLAB bring new perspectives and years of experience to our growing safety assessment team.

Headshot of Louis-Georges Guy, PhD, Director of Science, Charles River Boisbriand.

Louis-Georges Guy, PhD
Director of Science, Boisbriand

After receiving a PhD in molecular biology form Université de Montréal, Dr. Guy became project leader during an industrial postdoctoral fellowship at Angiogene. He later invented, developed, patented and licensed a cell and gene therapy approach to treat heart failure. He received a graduate diploma in management from HEC Montréal.

He comes to Charles River with the acquisition of AccelLAB, where he established the scientific program for the preclinical evaluation of medical devices in the fields of cardiology, ENT, orthopedics, and others. As an expert in bioabsorbable scaffolds, he has authored many articles, presented for sponsors in scientific meetings, and was invited as preclinical expert at a workshop at the FDA and a biodegradable metal symposium. Dr. Guy is an active member of the Society of Toxicology.

Headshot of Michel Assad, Associate Director Regulatory Affairs, Charles River.

Michel Assad
Executive Orthopedics and Biomaterials Director

Dr. Assad is an accomplished biomaterials scientist with more than 25 years of experience in preclinical research and product development. After obtaining his BS in biological sciences from McGill University, he went on to complete his Master’s in biomedical engineering and PhD in biomedical sciences at the University of Montreal. With expertise in biocompatibility, soft and hard tissue integration, and safety, efficacy and performance evaluation of orthopedic materials and biologics, Dr. Assad oversees all of our Boisbriand site's musculoskeletal research activities.

An active member of the US Orthopaedic Research Society (ORS) and US Society for Biomaterials, Dr. Assad frequently delivers scientific presentations in his field. He has authored more than 120 publications and scientific presentations and is associate editor of the biomaterials section of the Frontiers in Bioengineering and Biotechnology Journal.


Connect with Us

You’ll find our team at the following conferences:

  • TCT 2020 | Transcatheter Cardiovascular Therapeutics Annual Meeting – Miami, FL – September 23-27
  • NASS 2020 | 35th North American Spine Society Annual Meeting – San Diego, CA – October 7-11
  • WBC 2020 | 11th World Biomaterial Congress – Glasgow, Scotland – December 11-16

Stay Connected

Stay connected through this exciting transition by joining our mailing list. Sign up to keep in touch with our industry-leading scientists and receive news about the world-class product and device services and support that our expanded team provides.

Sign up

As new members of the Charles River team, we’re thrilled to be able to offer you even more of the science and service you know and trust.